InvestorsHub Logo

GS1

Followers 115
Posts 4767
Boards Moderated 0
Alias Born 07/11/2010

GS1

Re: None

Saturday, 11/22/2014 2:28:48 AM

Saturday, November 22, 2014 2:28:48 AM

Post# of 130502
As for Eltoprazine : We should get news in next couple of weeks.!!

We are looking forward to receiving pre-IND feedback from the FDA later in the fourth quarter and being able to open a new IND in the Neurology Division of FDA shortly thereafter. The Phase 2b trial is on schedule to start in early 2015. - See more at: http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/eltoprazine-lympro-manf-path-forward-value-creation/?utm_source=rss&utm_medium=rss&utm_campaign=eltoprazine-lympro-manf-path-forward-value-creation#sthash.pXDtqAIM.dpuf